» TECHNOVIEW® Edoxaban Cont Medium

HEMOSTASIS COAGULATION ROUTINE ANTICOAGULANT MONITORING DOAC EDOXABAN

TECHNOVIEW® Edoxaban Cont Medium

Lyophilized plasmas

Medium control plasmas for the dosage of edoxaban

TECHNOVIEW® Edoxaban Control Low quality control plasmas are titrated to approximately 125 ng / mL, optimized for anti-FXa methods.

Access on the manufacturer's website TECHNOCLONE

Reference	4-5090252
Presentation	Vial
Format	5 x 1.0 mL
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
4-5090252	Vial	5 x 1.0 mL

Price list, safety data sheets and notices are accessible to our registered customers.

Edoxaban is a direct and reversible highly selective inhibitor of FXa which decreases thrombin formation, prolongs clotting time and reduces the risk of thrombus formation.

TECHNOVIEW® Edoxaban plasmas are prepared from citrated plasmas supplemented with different concentrations of edoxaban and calibrated by the HPLC / MS - MS method.

- 5 vials x 1 mL lyophilized human plasma

TECHNOVIEW® Edoxaban Cal Set
TECHNOVIEW® Edoxaban Cont High
TECHNOVIEW® Edoxaban Cont Low

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION ROUTINE ANTICOAGULANT MONITORING DOAC EDOXABAN